| Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study M Siwek, D Dudek, IA Paul, M Sowa-Kućma, A Zięba, P Popik, A Pilc, ... Journal of affective disorders 118 (1-3), 187-195, 2009 | 244 | 2009 |
| -Antidepressant activity of zinc and magnesium in view of the current hypotheses of antidepressant action. B Szewczyk, E Poleszak, M Sowa-Kucma, M Siwek, D Dudek, ... Pharmacological Reports 60 (5), 588, 2008 | 200 | 2008 |
| Oxidative stress markers in affective disorders M Siwek, M Sowa-Kućma, D Dudek, K Styczeń, B Szewczyk, K Kotarska, ... Pharmacological Reports 65 (6), 1558-1571, 2013 | 155 | 2013 |
| Antidepressant-like activity of zinc: further behavioral and molecular evidence M Sowa-Kućma, B Legutko, B Szewczyk, K Novak, P Znojek, E Poleszak, ... Journal of neural transmission 115, 1621-1628, 2008 | 128 | 2008 |
| Lack of persistent effects of ketamine in rodent models of depression P Popik, T Kos, M Sowa-Kućma, G Nowak Psychopharmacology 198, 421-430, 2008 | 106 | 2008 |
| Zinc, magnesium and NMDA receptor alterations in the hippocampus of suicide victims M Sowa-Kućma, B Szewczyk, K Sadlik, W Piekoszewski, F Trela, ... Journal of affective disorders 151 (3), 924-931, 2013 | 97 | 2013 |
| Zinc as a marker of affective disorders M Siwek, B Szewczyk, D Dudek, K Styczeń, M Sowa-Kućma, K Młyniec, ... Pharmacological reports 65 (6), 1512-1518, 2013 | 92 | 2013 |
| Are there differences in lipid peroxidation and immune biomarkers between major depression and bipolar disorder: Effects of melancholia, atypical depression, severity of … M Sowa-Kućma, K Styczeń, M Siwek, P Misztak, RJ Nowak, D Dudek, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 81, 372-383, 2018 | 88 | 2018 |
| Antidepressant-like activity of magnesium in the chronic mild stress model in rats: alterations in the NMDA receptor subunits B Pochwat, B Szewczyk, M Sowa-Kucma, A Siwek, U Doboszewska, ... International Journal of Neuropsychopharmacology 17 (3), 393-405, 2014 | 86 | 2014 |
| The involvement of NMDA and AMPA receptors in the mechanism of antidepressant-like action of zinc in the forced swim test B Szewczyk, E Poleszak, M Sowa-Kućma, A Wróbel, S Słotwiński, J Listos, ... Amino Acids 39, 205-217, 2010 | 86 | 2010 |
| Vortioxetine: a review of the pharmacology and clinical profile of the novel antidepressant M Sowa-Kućma, P Pańczyszyn-Trzewik, P Misztak, RR Jaeschke, ... Pharmacological Reports 69, 595-601, 2017 | 72 | 2017 |
| The involvement of the GPR39-Zn (2+)-sensing receptor in the pathophysiology of depression. Studies in rodent models and suicide victims K Młyniec, U Doboszewska, B Szewczyk, M Sowa-Kućma, P Misztak, ... Neuropharmacology 79, 290-297, 2014 | 70 | 2014 |
| The serum zinc concentration as a potential biological marker in patients with major depressive disorder K Styczeń, M Sowa-Kućma, M Siwek, D Dudek, W Reczyński, B Szewczyk, ... Metabolic brain disease 32, 97-103, 2017 | 68 | 2017 |
| Lipid peroxidation and immune biomarkers are associated with major depression and its phenotypes, including treatment-resistant depression and melancholia M Sowa-Kućma, K Styczeń, M Siwek, P Misztak, RJ Nowak, D Dudek, ... Neurotoxicity Research 33, 448-460, 2018 | 67 | 2018 |
| Combined administration of PHCCC, a positive allosteric modulator of mGlu4 receptors and ACPT-I, mGlu III receptor agonist evokes antidepressant-like effects in rats K Kłak, A Pałucha, P Brański, M Sowa, A Pilc Amino acids 32, 169-172, 2007 | 67 | 2007 |
| Associations of serum cytokine receptor levels with melancholia, staging of illness, depressive and manic phases, and severity of depression in bipolar disorder M Siwek, M Sowa-Kućma, K Styczeń, P Misztak, RJ Nowak, B Szewczyk, ... Molecular neurobiology 54, 5883-5893, 2017 | 65 | 2017 |
| Time course of zinc deprivation-induced alterations of mice behavior in the forced swim test K Młyniec, CL Davies, B Budziszewska, W Opoka, W Reczyński, ... Pharmacological Reports 64 (3), 567-575, 2012 | 63 | 2012 |
| The role of the GPR39 receptor in zinc deficient-animal model of depression K Młyniec, B Budziszewska, W Reczyński, M Sowa-Kućma, G Nowak Behavioural brain research 238, 30-35, 2013 | 62 | 2013 |
| Histone deacetylases (HDACs) as therapeutic target for depressive disorders P Misztak, P Pańczyszyn-Trzewik, M Sowa-Kućma Pharmacological Reports 70 (2), 398-408, 2018 | 61 | 2018 |
| Antidepressant-like activity of magnesium in the olfactory bulbectomy model is associated with the AMPA/BDNF pathway B Pochwat, M Sowa-Kucma, K Kotarska, P Misztak, G Nowak, B Szewczyk Psychopharmacology 232, 355-367, 2015 | 58 | 2015 |
Gabriel NowakInstitute of Pharmacology, PAS & Jagiellonian University Medical College, Krakow, PolandVerified email at if-pan.krakow.pl
